Clinical Trial Update: A Study of Ultra High Dose Diuretics to Treat Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ultra-high-dose diuretics for heart failure with decompensation has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Ultra high-dose diuretics

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure; With Decompensation | Phase 2 | Status: COMPLETED | Results posted: 2026-01-14